Operational challenges in adaptive design implementation

Pharmaceutical Statistics

Volumn 5, Issue 2, 2006, Pages 119-124

  Gallo, Paul ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Data monitoring Committee; Group sequential trial; Interim analysis; Sample size re estimation; Seamless trial

Indexed keywords

PLACEBO;

ALGORITHM; CLINICAL RESEARCH; CONTROLLED STUDY; DATA ANALYSIS; DRUG RESEARCH; EXPERIMENTAL DESIGN; HUMAN; MEDICAL DECISION MAKING; RANDOMIZATION; REVIEW; SAMPLE SIZE; SENSITIVITY ANALYSIS; STATISTICAL MODEL; SYSTEM ANALYSIS; WELFARE;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DECISION MAKING; HUMANS; RESEARCH DESIGN;

EID: 33745175516     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.221     Document Type: Review

References (11)

1. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-1041.
2. Müller HH, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and classical group sequential approaches. Biometrics 2001; 57:886-891.
3. Cui L, Hung HMJ, Wang SJ. Modification of sample size in group sequential clinical trials. Biometrics 1999; 55:853-857.
4. Brannath W, König F, Bauer P. Improved repeated confidence bounds in trials with a maximal goal. Biometrical Journal 2003; 45:311-324.
5. Posch M, Koenig F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 2005; 24: 3697-3714.
6. US Food and Drug Administration. Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees. Rockville MD: FDA, 2006 (available at http://www.fda.gov/ cber/gdlns/clintrialdmc.htm).
7. Committee for Medicinal Products for Human Use. Guideline on Data Monitoring Committees. EMEA: London, 2005.
8. International Conference on Harmonisation Expert Working Group. ICH harmonised tripartite guideline: statistical principles for clinical trials. Federal Register 1998; 63:49583-49598.
9. Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical trials: a practical perspective. Wiley: Chichester, 2002.
10. Whitehead J. The design and analysis of sequential clinical trials. Wiley: Chichester, 1997.
11. Committee for Medicinal Products for Human Use. Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis plans. (Draft). EMEA: London; 2006.